R-alpha lipoate de sodium in food supplements
124 supplements declared in France contain R-alpha lipoate de sodium as a substance or active ingredient.
Other names in the Compl'Alim list: Na-RALA, Sodium R-lipoate.
Compl'Alim declarations. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
In plain words
À quoi il sert, selon les fabricants
Objectives most often stated for supplements that contain it (R-alpha lipoate de sodium): antioxydant (23 produits), immunité (7 produits), détoxifiant / draineur (5 produits), digestion (3 produits), minceur / glycémie (3 produits).
These are the objectives manufacturers declared to the authorities, not proven effects. On the packaging, only health claims authorised by the EU may be written.
Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Official warnings (Health Canada)
DL-ALPHA-LIPOIC ACID/R-ALPHA-LIPOIC ACID
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Jacob et al. 1999, Konrad et al. 1999, Packer et al. 1995).
Sources cited by Health Canada (3)
- Jacob S, Ruus P, Hermann R, Tritschler HJ, Maerker E, Renn W, Augustin HJ, Dietze GJ, Rett K. Oral administration of RAC-alpha-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial. Free Radical Biology & Medicine 1999;27(3-4):309-314. PubMed Randomised trial
- Konrad T, Vicini P, Kusterer K, Höflich A, Assadkhani A, Böhles HJ, Sewell A, Tritschler HJ, Cobelli C, Usadel KH. Alpha-Lipoic acid treatment decreases serum lactate and pyruvate concentrations and improves glucose effectiveness in lean and obese patients with type 2 diabetes. Diabetes Care 1999;22(2):280-287. PubMed
- Packer L, Witt EH, Tritschler HJ. Alpha-Lipoic acid as a biological antioxidant. Free Radical Biology & Medicine 1995;19(2):227-250. PubMed Review article
Applies to products providing 42 milligrams or more DL-alpha-lipoic acid or 21 milligrams or more R-alpha-lipoic acid, per day.
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if you experience sweating, paleness, chills, headache, dizziness and/or confusion (as these may be symptoms of serious low blood sugar) (Bae et al., 2013; Gullo et al., 2014; Bresciani et al., 2011; Chang et al., 2009).
Sources cited by Health Canada (4)
- Bae SM, Bae MN, Kim EY, Kim IK, Seo MW, Shin JK, Cho SR, Jeong GH. Recurrent Insulin Autoimmune Syndrome Caused by α-Lipoic Acid in Type 2 Diabetes. Endocrinol Metab (Seoul). 2013;28(4):326-330. PubMed
- Bresciani E, Bussi A, Bazzigaluppi E, Balestrieri G. Insulin autoimmune syndrome induced by α-lipoic acid in a Caucasian woman: case report. Diabetes Care. 2011 Sep;34(9):e146. doi: 10.2337/dc11-0600. DOI
- Chang HJ, Choi HS, Park MY, Leem SM, Jang YS, Park KS, Lee JM. A case of insulin autoimmune syndrome related to alpha-lipoic acid. Korean J Med 2009;76:600-604.
- Gullo D, Evans JL, Sortino G, Ira D. Goldfine and Vigneri R. Insulin autoimmune syndrome (Hirata Disease) in European Caucasians taking a-lipoic acid. Clinical Endocrinology 2014;81: 204-209. PubMed
Texts from the monograph of Health Canada, the Canadian authority, reproduced without modification. They do not replace medical advice.
What the registers say, country by country
Each line repeats what an official register says on the date it was consulted. Not being in a register means neither allowed nor banned.
Compl'Alim ingredient list (France): listed.
Compl'Alim, reference list of ingredients, retrieved 21 October 2026.
United States, supplement labels (DSLD; supplements need no prior approval): 24 products.
Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
What we know about this ingredient
Scientific publications (PubMed)
3 records published in the five years before 12 November 2026. The name is searched in the title or abstract; derivatives and passing mentions can be counted. This count does not measure effectiveness.
Searched on 12 November 2026.
Products
- A Amincissant Ahres Santé, gélule, declared in 2021
- ACIDE ALPHA LIPOIQUE SANTEREL, gélule, declared in 2022
- ACIDE ALPHA-LIPOIQUE PREMIUM gélule, declared in 2024
- ACIDE R ALPHA LIPOIQUE Vitanutrics, gélule, declared in 2018
- ACIDE R-ALPHA LIPOÏQUE gélule, declared in 2024
- ACIDE R-ALPHA LIPOÏQUE gélule, declared in 2026
- ACIDE R-ALPHA-LIPOÏQUE gélule, declared in 2024
- ACIDE R-ALPHA-LIPOÏQUE LIPOSOMAL flacon, declared in 2025
- ACIDE R-ALPHA-LIPOÏQUE LIPOSOMAL flacon, declared in 2026
- AR321 R-ALPHA-LIPONSÄURE 300 mg 180 Kapseln YOUR HEALTH, gélule, declared in 2026
- ASQINOX + gélule, declared in 2022
- Acide Alpha Lipoïque CRYOLEAN, comprimé, declared in 2022
- Acide Alpha Lipoïque CRYOLEAN, comprimé, declared in 2023
- Acide R Alpha Lipoique sofibio, gélule, declared in 2025
- Acide R alpha lipoique gélule, declared in 2024
- Acide R alpha lipoique gélule, declared in 2017
- Acide R alpha lipoique gélule, declared in 2020
- Acide R-ALA Bio-Enhanced® gélule, declared in 2019
- Acide R-Alpha Lipoique DYNVEO, gélule, declared in 2018
- Acide alpha lipoïque Onatera, gélule, declared in 2025
- Acide alpha-lipoïque VIT'ALL+, gélule, declared in 2017
- Acide-R-alpha-lipoïque comprimé, declared in 2025
- Activ-Hépato Lorica, gélule, declared in 2026
- Antidot métaux lourds CILouette, gélule, declared in 2022
- Antidot perturbateurs endocriniens CILouette, gélule, declared in 2022
- Antiflamage atox origen pure, gélule, declared in 2018
- Antinflamage Atox origen pure, gélule, declared in 2018
- AoDyn poudre, declared in 2021
- COMPLEXE BROUILLARD* MENTAL gélule, declared in 2025
- COMPLEXE DOPA gélule, declared in 2026
- COMPLEXE SIRT 1 - AMPK gélule, declared in 2026
- Complexe Audition VIT'ALL +, gélule, declared on 7 June 2019
- Complexe Audition VIT'ALL +, gélule, declared on 25 September 2019
- Complexe Longévité VIT'ALL +, gélule, declared in 2019
- Complexe antioxydant comprimé, declared in 2025
- CycloSoft Nutrixeal, gélule, declared in 2025
- DétoXéno Royal La Royale, sachet, declared in 2022
- Glutyl 2 Phybiotech France, gélule, declared in 2025
- Glutyl 2 RLP CONCEPT, gélule, declared in 2021
- Glutyl Extra PHYBIOTECH FRANCE, gélule, declared in 2025
- HebeDyn gélule, declared in 2021
- HebeDyn comprimé comprimé, declared in 2024
- Hebenox® comprimé, declared in 2025
- Hebexina gélule, declared in 2019
- IMUVITAL poudre, declared in 2019
- InnéVie gélule, declared in 2025
- Innévie gélule, declared in 2025
- LIPOSOMAL VITAMIN C + R-LIPOIC ACID QUICKSILVER SCIENTIFIC, spray, declared in 2025
- LIVER SAUCE QUICKSILVER SCIENTIFIC, flacon, declared in 2025
- LIVERVITALPRO capsule, declared in 2024
- Liver Support Formula SuperSmart, gélule, declared in 2025
- METAFERRINE + Lisarce, gélule, declared in 2026
- METAPLEXINE LISARCE, gélule, declared in 2018
- METOX VITAL VIT'ALL +, gélule, declared in 2019
- MITO REGEN gélule, declared in 2021
- MITO REGEN gélule, declared in 2025
- MITO REGEN gélule, declared in 2026
- Meta Lipoate comprimé, declared in 2018
- MetaClear comprimé, declared in 2018
- MitoDyn gélule, declared in 2018
Other related records
- Alcohol Detox Supplement from the US market
- Sodium R-Lipoate 600 mg Supplement from the US market
- Rehab Supplement from the US market
- Neuro Nutrition Formula Supplement from the US market
- Liver Support Formula Supplement from the US market
- OptiVision Supplement from the US market
- Daily 2 Timed Release Multivitamin Supplement from the US market
- Blade : étiquette retirée du marché américain Supplement from the US market, 61442000034
- P.P.K. Blue Raspberry Supplement from the US market
- P.P.K. Cream Soda Supplement from the US market
- P.P.K. Pineapple Mango Supplement from the US market
- AminoFast Watermelon Supplement from the US market
- AminoFast White Freezie Supplement from the US market
- AminoFast Pink Lemonade Supplement from the US market
- AminoFast Pineapple Mango Supplement from the US market
- Post-Factor Chocolate Truffle Supplement from the US market
- Post-Factor Blueberry Pomegranate Supplement from the US market
- Post-Factor Key Lime Pie Supplement from the US market
- Crea-Tech Supplement from the US market
- Blade : étiquette retirée du marché américain Supplement from the US market, 61442000812
- P.P.K. Grape Supplement from the US market
- AminoFast Peach Supplement from the US market
- GlycoLog Supplement from the US market
- Sodium R-Lipoate 300 mg : étiquette retirée du marché américain Supplement from the US market
Cite this page: CompoAtlas, “R-alpha lipoate de sodium: food supplements and declared doses”, https://compoatlas.com/en/supplements/ingredients/r-alpha-lipoate-de-sodium, updated 15 November 2026.